Changchun Hibo Biotechnology

Changchun Hibo Biotechnology is a Chinese biopharmaceutical company specializing in the research, development, and manufacturing of human vaccines. The company is best known for its production of the Human Rabies Vaccine (Vero Cell), which is widely used for post-exposure prophylaxis. In addition to its rabies vaccine, Hibo Biotechnology focuses on other viral vaccines, including those for Hepatitis A and influenza. The company operates large-scale manufacturing facilities in Changchun, Jilin Province, and maintains a significant presence in the domestic Chinese immunization market. Its business model integrates R&D with high-volume production to meet public health demands for essential infectious disease prevention.